63 related articles for article (PubMed ID: 23485045)
1. Subconjunctival triamcinolone acetonide in the management of ocular inflammatory disease.
Athanasiadis Y; Tsatsos M; Sharma A; Hossain P
J Ocul Pharmacol Ther; 2013; 29(6):516-22. PubMed ID: 23485045
[TBL] [Abstract][Full Text] [Related]
2. Enigma of Intramuscular Triamcinolone Acetonide (Kenalog
Shahinfar S; Maibach H
Clin Pharmacokinet; 2023 Sep; 62(9):1189-1199. PubMed ID: 37598107
[TBL] [Abstract][Full Text] [Related]
3. Effect of pretreatment with local corticosteroids on antibody-forming cells in the eye and draining lymph nodes.
Hall JM; Meyer RF; Smolin G; Okumoto M
Can J Ophthalmol; 1975 Oct; 10(4):487-93. PubMed ID: 53091
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Subconjunctival Triamcinolone Acetate-associated Scleral Necrosis: Is It Really Obsolete?
Agarwal R; Bafna RK; Chetan C; Sharma N
Optom Vis Sci; 2021 Sep; 98(9):1016-1020. PubMed ID: 34433205
[TBL] [Abstract][Full Text] [Related]
5. Analytical Methods for Triamcinolone Acetonide: An Exploratory Literature Review.
Gulati D; Saini A; Dhingra AK
Antiinflamm Antiallergy Agents Med Chem; 2023; 22(2):71-78. PubMed ID: 37842891
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory eye disease for rheumatologists.
Corbitt K; Nowatzky J
Curr Opin Rheumatol; 2023 May; 35(3):201-212. PubMed ID: 36943695
[TBL] [Abstract][Full Text] [Related]
7. Subconjunctival therapy by cubic liquid crystalline nanoparticles to deliver Triamcinolone acetonide for the management of diabetic Retinopathy: In vivo evidences.
Sharadha M; Vishal Gupta N; Rahamathulla M; Muqtader Ahmed M; Ayesha Farhana S; Osmani RAM; Veeranna B; Koteshwara KB
Int J Pharm; 2023 Nov; 646():123443. PubMed ID: 37748633
[TBL] [Abstract][Full Text] [Related]
8. Triamcinolone acetonide alleviates benign biliary stricture by ameliorating biliary fibrosis and inflammation.
Joo S; Lee SY; Lee SY; Hwang Y; Kim M; Jeong JW; Jang SI; Fang S
BMB Rep; 2024 Apr; 57(4):200-205. PubMed ID: 38523372
[TBL] [Abstract][Full Text] [Related]
9. Sustained release intraocular drug delivery devices for treatment of uveitis.
Haghjou N; Soheilian M; Abdekhodaie MJ
J Ophthalmic Vis Res; 2011 Oct; 6(4):317-29. PubMed ID: 22454753
[TBL] [Abstract][Full Text] [Related]
10. Advanced drug delivery and targeting technologies for the ocular diseases.
Barar J; Aghanejad A; Fathi M; Omidi Y
Bioimpacts; 2016; 6(1):49-67. PubMed ID: 27340624
[TBL] [Abstract][Full Text] [Related]
11. Subconjunctival dexamethasone-assisted conjunctival autograft harvesting versus normal saline during pterygium surgery - A randomized clinical trial.
Meena A; Agrawal A; Parmar G; Gurnani B
Indian J Ophthalmol; 2024 Feb; 72(2):217-222. PubMed ID: 38099381
[TBL] [Abstract][Full Text] [Related]
12. Sub-Tenon's capsule triamcinolone acetonide injection to prevent brolucizumab-associated intraocular inflammation.
Hikichi T
Graefes Arch Clin Exp Ophthalmol; 2022 Aug; 260(8):2529-2535. PubMed ID: 35235038
[TBL] [Abstract][Full Text] [Related]
13. Prednisolone and Ketorolac vs Ketorolac Monotherapy or Sub-Tenon Prophylaxis for Macular Thickening in Cataract Surgery: A Randomized Clinical Trial.
Erichsen JH; Holm LM; Forslund Jacobsen M; Forman JL; Kessel L
JAMA Ophthalmol; 2021 Oct; 139(10):1062-1070. PubMed ID: 34383010
[TBL] [Abstract][Full Text] [Related]
14. Development of Triamcinolone Acetonide-Loaded Microemulsion as a Prospective Ophthalmic Delivery System for Treatment of Uveitis: In Vitro and In Vivo Evaluation.
Mahran A; Ismail S; Allam AA
Pharmaceutics; 2021 Mar; 13(4):. PubMed ID: 33805986
[TBL] [Abstract][Full Text] [Related]
15. Subconjunctival injections of triamcinolone acetonide to treat uveitic macular edema.
Qu Y; Liu XS; Liang AY; Xiao JY; Zhao C; Gao F; Zhang MF
Int J Ophthalmol; 2020; 13(7):1087-1091. PubMed ID: 32685396
[TBL] [Abstract][Full Text] [Related]
16. Local delivery of corticosteroids in clinical ophthalmology: A review.
Fung AT; Tran T; Lim LL; Samarawickrama C; Arnold J; Gillies M; Catt C; Mitchell L; Symons A; Buttery R; Cottee L; Tumuluri K; Beaumont P
Clin Exp Ophthalmol; 2020 Apr; 48(3):366-401. PubMed ID: 31860766
[TBL] [Abstract][Full Text] [Related]
17. Periocular triamcinolone acetonide injection for treating polypoidal choroidal vasculopathy concurrent with hemorrhagic retinal detachment.
Zhang K; Chen Y; Sun X; Zhong Q; Lin L; Gao Y; Hong F
Medicine (Baltimore); 2018 Sep; 97(39):e12464. PubMed ID: 30278530
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous Subconjunctival Triamcinolone and Bevacizumab Injections for Management of Blepharokeratoconjunctivitis in Children.
Nguyen CL; Chen TS; Tran K; Smith JEH; Lewis N
Case Rep Ophthalmol Med; 2018; 2018():2602487. PubMed ID: 29967706
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis.
Wong CW; Czarny B; Metselaar JM; Ho C; Ng SR; Barathi AV; Storm G; Wong TT
Sci Rep; 2018 Apr; 8(1):6604. PubMed ID: 29700320
[TBL] [Abstract][Full Text] [Related]
20. Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation.
Soiberman U; Kambhampati SP; Wu T; Mishra MK; Oh Y; Sharma R; Wang J; Al Towerki AE; Yiu S; Stark WJ; Kannan RM
Biomaterials; 2017 May; 125():38-53. PubMed ID: 28226245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
